Literature DB >> 17384013

Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review.

Aldo Clerico1, Marianna Fontana, Luc Zyw, Claudio Passino, Michele Emdin.   

Abstract

BACKGROUND: We used evidence-based laboratory medicine principles to compare the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) assays for the diagnosis of heart failure.
METHODS: In May 2006, we performed a computerized literature search of the online National Library of Medicine to select studies specifically designed to compare the diagnostic accuracy of BNP and NT-proBNP assays. The comparison took into account the area under the curve and diagnostic odds ratio (DOR) derived from ROC analysis of original studies.
RESULTS: Both BNP and NT-proBNP assays were found to be clinically useful for the diagnosis of heart failure. Metaanalysis of these data was difficult because of the heterogeneity of data regarding patient population, diagnostic criteria, end-points, and immunoassay methods for both BNP and NT-proBNP. Separate metaanalyses were performed for acute and chronic heart failure. In chronic heart failure, the diagnostic DOR for BNP (8.44, 95% CI 4.66-15.30) was not significantly different from that of NT-proBNP (23.36, 95% CI 9.38-58.19). In patients with acute heart failure, the mean DOR for BNP (16.46, 95% CI 10.65-25.43) was not significantly different from that of NT-proBNP (18.61, 95% CI 12.99-26.65).
CONCLUSION: Our results indicate that both BNP and NT-proBNP assays have a high degree of diagnostic accuracy and clinical relevance for both acute and chronic heart failure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17384013     DOI: 10.1373/clinchem.2006.075713

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  29 in total

1.  Classification of heart failure in the atherosclerosis risk in communities (ARIC) study: a comparison of diagnostic criteria.

Authors:  Wayne D Rosamond; Patricia P Chang; Chris Baggett; Anna Johnson; Alain G Bertoni; Eyal Shahar; Anita Deswal; Gerardo Heiss; Lloyd E Chambless
Journal:  Circ Heart Fail       Date:  2012-01-23       Impact factor: 8.790

2.  Canadian Cardiovascular Society Consensus Conference update on cardiac transplantation 2008: Executive Summary.

Authors:  H Haddad; D Isaac; J F Legare; P Pflugfelder; P Hendry; M Chan; B Cantin; N Giannetti; S Zieroth; M White; W Warnica; K Doucette; V Rao; A Dipchand; M Cantarovich; W Kostuk; R Cecere; E Charbonneau; H Ross; N Poirier
Journal:  Can J Cardiol       Date:  2009-04       Impact factor: 5.223

Review 3.  Natriuretic peptide-guided treatment for the prevention of cardiovascular events in patients without heart failure.

Authors:  Claire Sweeney; Fiona Ryan; Mark Ledwidge; Cristin Ryan; Ken McDonald; Chris Watson; Rebabonye B Pharithi; Joe Gallagher
Journal:  Cochrane Database Syst Rev       Date:  2019-10-15

4.  BNP as a marker for early prediction of anthracycline-induced cardiotoxicity in patients with breast cancer.

Authors:  Xiang Lu; Yingying Zhao; Caiping Chen; Chao Han; Li Xue; Dan Xing; Ou Huang; Min Tao
Journal:  Oncol Lett       Date:  2019-09-09       Impact factor: 2.967

Review 5.  The paradox of low BNP levels in obesity.

Authors:  Aldo Clerico; Alberto Giannoni; Simona Vittorini; Michele Emdin
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

6.  B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial.

Authors:  Peder Langeland Myhre; Muthiah Vaduganathan; Brian Claggett; Milton Packer; Akshay S Desai; Jean L Rouleau; Michael R Zile; Karl Swedberg; Martin Lefkowitz; Victor Shi; John J V McMurray; Scott D Solomon
Journal:  J Am Coll Cardiol       Date:  2019-03-04       Impact factor: 24.094

7.  The effect of the brain-type natriuretic peptide single-nucleotide polymorphism rs198389 on test characteristics of common assays.

Authors:  Lisa C Costello-Boerrigter; Guido Boerrigter; Syed Ameenuddin; Douglas W Mahoney; Joshua P Slusser; Denise M Heublein; Margaret M Redfield; Richard J Rodeheffer; Timothy M Olson; John C Burnett
Journal:  Mayo Clin Proc       Date:  2011-03       Impact factor: 7.616

Review 8.  B-type natriuretic peptide-guided treatment for heart failure.

Authors:  Julie McLellan; Carl J Heneghan; Rafael Perera; Alison M Clements; Paul P Glasziou; Karen E Kearley; Nicola Pidduck; Nia W Roberts; Sally Tyndel; F Lucy Wright; Clare Bankhead
Journal:  Cochrane Database Syst Rev       Date:  2016-12-22

Review 9.  Natriuretic peptides in the diagnosis and management of chronic heart failure.

Authors:  Guido Boerrigter; Lisa C Costello-Boerrigter; John C Burnett
Journal:  Heart Fail Clin       Date:  2009-10       Impact factor: 3.179

Review 10.  The current role of cardiac resynchronization therapy in reducing mortality and hospitalization in heart failure patients: a meta-analysis from clinical trials.

Authors:  Andrea Rossi; Giuseppe Rossi; Marcello Piacenti; Umberto Startari; Luca Panchetti; Maria-Aurora Morales
Journal:  Heart Vessels       Date:  2008-07-23       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.